Ricevi le ultime notizie sulle azioni Macrogenics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di MGNX

Ultime notizie per

MACROGENICS INC

Macrogenics

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.

Macrogenics Inc

Press Releases

MacroGenics to Participate in Upcoming Investor Conference

MacroGenics Announces Date of First Quarter 2025 Financial Results

Earnings

MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

News

Power Metallic (TSXV: PNPN) (OTCQB: PNPNF) Positioned for Critical Minerals Breakout Following Acquisition – More Stocks Inside

Synergy CHC (NASDAQ: SNYR) Taps Coca-Cola Exec to Accelerate Global Expansion of "FOCUSfactor®" Energy Drink – More Stocks Moving Inside

MacroGenics Appoints Eric Risser as President and Chief Executive Officer

MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities

MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference

AMZN

COST

EVGN

KLTO

MEGL

MGNX

MRIN

PLUG

PNPNF

PRSO

SNYR

TSXV:PNPN

WINT

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Atossa Therapeutics

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Coya Therapeutics

EXoZymes

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

TuHURA Biosciences

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Immix Biopharma

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Opus Genetics

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

MDxHealth

Metagenomi

NewAmsterdam Pharma Company N.V. - Warrant

NewAmsterdam Pharma Co

Oncolytics Biotech

Ovid Therapeutics

Pelthos Therapeutics

AVITA Medical

Spero Therapeutics

Surrozen

Tevogen Bio Holdings

Whitehawk Therapeutics, Inc. - Common Stock

Whitehawk Therapeutics

Zentalis Pharmaceuticals, Inc. - common stock

Zentalis Pharma

Barclays

Leerink Partners

B. Riley Securities

Stifel

Comments

Macrogenics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO